Obesity and aspirin intolerance are risk factors for difficult-to-treat asthma in Japanese non-atopic women

Clinical and Experimental Allergy

Volumn 42, Issue 5, 2012, Pages 738-746

  Fukutomi, Y ^a,b   Taniguchi, M ^a   Tsuburai, T ^a   Tanimoto, H ^a   Oshikata, C ^a   Ono, E ^a   Sekiya, K ^a   Higashi, N ^a   Mori, A ^a   Hasegawa, M ^a   Nakamura, H ^b   Akiyama, K ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Aspirin intolerance; Asthma phenotype; Difficult to treat asthma; Gender difference; Obesity

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BODY MASS; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; ASTHMA; BODY MASS INDEX; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; JAPAN; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; RISK FACTORS; SEX FACTORS;

EID: 84856936199     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03880.x     Document Type: Article

References (29)

1. GINA Report, Global Strategy for Asthma Management and Prevention 2009 (update). Available at http://www.ginasthma.com (accessed 25 October 2010).
2. Antonicelli L, Bucca C, Neri M et al. Asthma severity and medical resource utilisation. Eur Respir J 2004; 23:723-9.
3. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 2002; 19:61-7.
4. Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12:1322-6.
5. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005; 115:897-909; quiz 910.
6. Coogan PF, Palmer JR, O'Connor GT, Rosenberg L. Body mass index and asthma incidence in the Black Women's Health Study. J Allergy Clin Immunol 2009; 123:89-95.
7. Chen Y, Dales R, Tang M, Krewski D. Obesity may increase the incidence of asthma in women but not in men: longitudinal observations from the Canadian National Population Health Surveys. Am J Epidemiol 2002; 155:191-7.
8. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22:470-7.
9. Wenzel SE, Busse WW. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:14-21; quiz 22-13.
10. Moore WC, Meyers DA, Wenzel SE et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010; 181:315-23.
11. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
12. Mita H, Endoh S, Kudoh M et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy 2001; 56:1061-7.
13. Varraso R, Siroux V, Maccario J, Pin I, Kauffmann F. Asthma severity is associated with body mass index and early menarche in women. Am J Respir Crit Care Med 2005; 171:334-9.
14. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-63.
15. Nakagami T, Qiao Q, Carstensen B et al. Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia 2003; 46:1063-70.
16. Nagaya T, Yoshida H, Takahashi H, Kawai M. Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population. Diabet Med 2005; 22:1107-11.
17. Olafsdottir IS, Gislason T, Thjodleifsson B et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005; 60:451-4.
18. Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2005; 116:970-5.
19. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000; 16:432-6.
20. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002; 89:474-8.
21. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992; 3:452-6.
22. Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320:827-32.
23. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000; 118:1315-21.
24. Maniscalco M, Zedda A, Faraone S et al. Weight loss and asthma control in severely obese asthmatic females. Respir Med 2008; 102:102-8.
25. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996; 98:751-8.
26. Rozsasi A, Polzehl D, Deutschle T et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008; 63:1228-34.
27. Dolan CM, Fraher KE, Bleecker ER et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2004; 92:32-9.
28. Appleton SL, Adams RJ, Wilson DH, Taylor AW, Ruffin RE. Central obesity is associated with nonatopic but not atopic asthma in a representative population sample. J Allergy Clin Immunol 2006; 118:1284-91.
29. De Smet BD, Erickson SR, Kirking DM. Self-reported adherence in patients with asthma. Ann Pharmacother 2006; 40:414-20.